New Markers of Disease Progression in Myelofibrosis

SIMPLE SUMMARY: Disease progression and prognosis in PMF are usually associated with worsening of anemia, increase of circulating blasts, and, more recently, with the presence, in addition to the “classical” driver mutations, of JAK2, MPL, and CALR genes, as well as of cytogenetic and molecular abno...

Descripción completa

Detalles Bibliográficos
Autores principales: Campanelli, Rita, Massa, Margherita, Rosti, Vittorio, Barosi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582535/
https://www.ncbi.nlm.nih.gov/pubmed/34771488
http://dx.doi.org/10.3390/cancers13215324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582535/
https://www.ncbi.nlm.nih.gov/pubmed/34771488
http://dx.doi.org/10.3390/cancers13215324

Ejemplares similares